• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Human Papillomavirus Vaccination in Washington State: Estimated Coverage and Missed Opportunities, 2006-2013.华盛顿州的人乳头瘤病毒疫苗接种情况:2006 - 2013年估计覆盖率及错失的机会
Public Health Rep. 2016 May-Jun;131(3):474-82. doi: 10.1177/003335491613100313.
2
Statewide analysis of missed opportunities for human papillomavirus vaccination using vaccine registry data.利用疫苗登记数据对人乳头瘤病毒疫苗接种错失机会进行的全州范围分析。
Papillomavirus Res. 2016 Dec;2:128-132. doi: 10.1016/j.pvr.2016.06.002.
3
Missed opportunities for adolescent vaccination, 2006-2011.2006-2011 年青少年疫苗接种错失时机。
J Adolesc Health. 2013 Oct;53(4):492-7. doi: 10.1016/j.jadohealth.2013.05.009. Epub 2013 Jul 1.
4
Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.在马拉维实施人乳头瘤病毒疫苗示范项目:成功经验与挑战
BMC Public Health. 2017 Jun 26;17(1):599. doi: 10.1186/s12889-017-4526-y.
5
Human Papillomavirus Vaccine Coverage and Prevalence of Missed Opportunities for Vaccination in an Integrated Healthcare System.人乳头瘤病毒疫苗接种覆盖率和综合性医疗保健系统中错过疫苗接种机会的情况。
Acad Pediatr. 2018 Mar;18(2S):S85-S92. doi: 10.1016/j.acap.2017.09.002.
6
Comparing human papillomavirus vaccine knowledge and intentions among parents of boys and girls.比较男孩和女孩父母对人乳头瘤病毒疫苗的了解情况及接种意愿。
Hum Vaccin Immunother. 2016 Jun 2;12(6):1519-27. doi: 10.1080/21645515.2016.1157673. Epub 2016 Mar 22.
7
Correlates of human papillomavirus vaccine coverage: a state-level analysis.人乳头瘤病毒疫苗接种覆盖率的相关因素:一项州级分析。
Sex Transm Dis. 2015 Feb;42(2):71-5. doi: 10.1097/OLQ.0000000000000225.
8
The Longitudinal Incidence of Human Papillomavirus Vaccination in Spanish Primary Care in the First 10 Years After Approval.人乳头瘤病毒疫苗在西班牙初级保健机构获批后的首个十年中的纵向接种率
Pharmaceut Med. 2019 Dec;33(6):519-530. doi: 10.1007/s40290-019-00309-9.
9
Inconclusive evidence for non-inferior immunogenicity of two- compared with three-dose HPV immunization schedules in preadolescent girls: A systematic review and meta-analysis.关于在青春期前女孩中,两剂与三剂 HPV 免疫接种方案相比免疫原性非劣效性的不确定证据:系统评价和荟萃分析。
J Infect. 2015 Jul;71(1):61-73. doi: 10.1016/j.jinf.2015.02.005. Epub 2015 Feb 21.
10
Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.2007 - 2013年美国青少年人乳头瘤病毒疫苗接种覆盖率及2006 - 2014年疫苗上市后安全性监测
MMWR Morb Mortal Wkly Rep. 2014 Jul 25;63(29):620-4.

引用本文的文献

1
Factors contributing to missed opportunities for human papillomavirus vaccination among adolescents, ages 11 to 13, in Iowa.爱荷华州11至13岁青少年人乳头瘤病毒疫苗接种错失机会的相关因素。
Vaccine X. 2022 Jul 9;11:100192. doi: 10.1016/j.jvacx.2022.100192. eCollection 2022 Aug.
2
The Use of Medical Claims Data for Identifying Missed Opportunities for HPV Immunization Among Privately Insured Adolescents in the State of Iowa.利用医疗索赔数据识别爱荷华州私人保险青少年中 HPV 免疫接种的错失机会
J Community Health. 2022 Oct;47(5):783-789. doi: 10.1007/s10900-022-01110-7. Epub 2022 Jun 17.
3
Missed opportunities for human papillomavirus vaccine series initiation in a large, rural U.S. state.美国一大型农村州错过人乳头瘤病毒疫苗系列接种的机会。
Hum Vaccin Immunother. 2022 Jan 31;18(1):2016304. doi: 10.1080/21645515.2021.2016304. Epub 2022 Feb 4.
4
Regional variations in human papillomavirus prevalence across time in NHANES (2003-2014).NHANES(2003-2014 年)中 HPV 流行率的地域差异随时间变化。
Vaccine. 2019 Jul 9;37(30):4040-4046. doi: 10.1016/j.vaccine.2019.06.001. Epub 2019 Jun 7.
5
Countering vaccine hesitancy through immunization information systems, a narrative review.通过免疫信息系统应对疫苗犹豫:叙事性综述。
Hum Vaccin Immunother. 2019;15(11):2508-2526. doi: 10.1080/21645515.2019.1599675. Epub 2019 Jun 21.
6
Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26 year old females in the U.S.人乳头瘤病毒疫苗接种对美国 14-26 岁女性中疫苗型人乳头瘤病毒流行率的种族/民族差异的影响
Vaccine. 2018 Nov 29;36(50):7682-7688. doi: 10.1016/j.vaccine.2018.10.075. Epub 2018 Oct 28.
7
Human Papillomavirus Vaccine Coverage and Prevalence of Missed Opportunities for Vaccination in an Integrated Healthcare System.人乳头瘤病毒疫苗接种覆盖率和综合性医疗保健系统中错过疫苗接种机会的情况。
Acad Pediatr. 2018 Mar;18(2S):S85-S92. doi: 10.1016/j.acap.2017.09.002.
8
Improving HPV Vaccination Through a Diverse Multi-state Coalition.通过多元化的多州联盟提高 HPV 疫苗接种率。
J Community Health. 2017 Oct;42(5):911-920. doi: 10.1007/s10900-017-0334-7.

本文引用的文献

1
National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years--United States, 2013.2013年美国13至17岁青少年的全国、地区、州及部分局部地区疫苗接种覆盖率
MMWR Morb Mortal Wkly Rep. 2014 Jul 25;63(29):625-33.
2
Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.2007 - 2013年美国青少年人乳头瘤病毒疫苗接种覆盖率及2006 - 2014年疫苗上市后安全性监测
MMWR Morb Mortal Wkly Rep. 2014 Jul 25;63(29):620-4.
3
HPV vaccination: are we initiating too late?HPV 疫苗接种:我们是否开始得太晚了?
Vaccine. 2014 Apr 7;32(17):1939-45. doi: 10.1016/j.vaccine.2014.01.084. Epub 2014 Feb 14.
4
CDC grand rounds: Reducing the burden of HPV-associated cancer and disease.美国疾病预防控制中心例会:降低 HPV 相关癌症和疾病的负担。
MMWR Morb Mortal Wkly Rep. 2014 Jan 31;63(4):69-72.
5
Evaluating Washington State's immunization information system as a research tool.评估华盛顿州免疫信息系统作为一种研究工具的情况。
Acad Pediatr. 2014 Jan-Feb;14(1):71-6. doi: 10.1016/j.acap.2013.10.002.
6
Inequalities in the uptake of human papillomavirus vaccination: a systematic review and meta-analysis.人乳头瘤病毒疫苗接种率的不平等:系统评价和荟萃分析。
Int J Epidemiol. 2013 Jun;42(3):896-908. doi: 10.1093/ije/dyt049. Epub 2013 Apr 25.
7
Timeliness and data element completeness of immunization data in Washington State in 2010: a comparison of data exchange methods.2010年华盛顿州免疫数据的及时性和数据元素完整性:数据交换方法的比较
AMIA Annu Symp Proc. 2012;2012:340-9. Epub 2012 Nov 3.
8
Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.《1975-2009 年全国癌症报告:人乳头瘤病毒(HPV)相关癌症的负担和趋势以及 HPV 疫苗接种覆盖率》
J Natl Cancer Inst. 2013 Feb 6;105(3):175-201. doi: 10.1093/jnci/djs491. Epub 2013 Jan 7.
9
Correlates of human papillomavirus vaccination rates in low-income, minority adolescents: a multicenter study.低收入少数民族青少年人乳头瘤病毒疫苗接种率的相关因素:一项多中心研究。
J Womens Health (Larchmt). 2012 Aug;21(8):813-20. doi: 10.1089/jwh.2011.3364.
10
An update on human papillomavirus vaccine uptake among 11-17 year old girls in the United States: National Health Interview Survey, 2010.美国 11-17 岁女孩中人类乳头瘤病毒疫苗接种情况的最新进展:2010 年全国健康访谈调查。
Vaccine. 2012 May 21;30(24):3534-40. doi: 10.1016/j.vaccine.2012.03.067. Epub 2012 Apr 3.

华盛顿州的人乳头瘤病毒疫苗接种情况:2006 - 2013年估计覆盖率及错失的机会

Human Papillomavirus Vaccination in Washington State: Estimated Coverage and Missed Opportunities, 2006-2013.

作者信息

Oltean Hanna N, Lofy Kathryn H, Goldoft Marcia J, DeBolt Charla A

机构信息

Washington State Department of Health, Office of Communicable Disease Epidemiology, Shoreline, WA.

出版信息

Public Health Rep. 2016 May-Jun;131(3):474-82. doi: 10.1177/003335491613100313.

DOI:10.1177/003335491613100313
PMID:27252567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4869078/
Abstract

OBJECTIVE

Human papillomavirus (HPV) causes almost all cervical cancer in women and contributes to vaginal, anal, oropharyngeal, and penile cancer morbidity and mortality. Although vaccines effective in preventing up to nine types of HPV are available, vaccination rates are low nationally. We assessed HPV vaccination coverage by age, sex, and county using Washington State Immunization Information System data.

METHODS

We calculated on-time dose coverage by county and statewide among adolescents aged 11-12 years and assessed coverage by age 18 years. We calculated missed opportunities as the number of visits at which doses of other adolescent vaccines were administered without administration of the first dose of HPV vaccine (HPV1).

RESULTS

In 2013, HPV vaccination coverage estimates with one, two, and three doses (HPV1-3) for adolescents aged 11-12 years were 48.5%, 32.4%, and 18.3% among girls and 31.2%, 17.1%, and 8.1% among boys. The three-dose HPV vaccine coverage estimate increased to 40.1% among girls by age 18 but was unchanged for boys. Coverage estimates varied by age, sex, and county. One-third of eligible unvaccinated girls and two of five eligible boys aged 11-17 years had at least one missed opportunity to receive HPV1.

CONCLUSION

Despite a recommendation to vaccinate adolescents aged 11-12 years, HPV vaccination is often delayed and coverage levels among all age groups are below national target levels. Improved understanding of the variability of HPV vaccination coverage rates by age, sex, and county can inform targeted interventions statewide.

摘要

目的

人乳头瘤病毒(HPV)几乎引发了所有女性宫颈癌,并导致阴道癌、肛门癌、口咽癌和阴茎癌的发病及死亡。尽管已有可有效预防多达九种HPV类型的疫苗,但全国范围内的疫苗接种率较低。我们利用华盛顿州免疫信息系统数据,按年龄、性别和县域评估了HPV疫苗接种覆盖率。

方法

我们计算了11至12岁青少年在各县及全州范围内的按时接种剂量覆盖率,并评估了18岁时的覆盖率。我们将错过的接种机会计算为在接种其他青少年疫苗时未接种首剂HPV疫苗(HPV1)的就诊次数。

结果

2013年,11至12岁青少年中,一剂、两剂和三剂(HPV1 - 3)HPV疫苗接种覆盖率在女孩中分别为48.5%、32.4%和18.3%,在男孩中分别为31.2%、17.1%和8.1%。到18岁时,女孩的三剂HPV疫苗接种覆盖率估计增至40.1%,但男孩的覆盖率未变。覆盖率估计因年龄、性别和县域而异。11至17岁符合条件但未接种疫苗的女孩中有三分之一、男孩中有五分之二至少有一次错过接种HPV1的机会。

结论

尽管建议为11至12岁青少年接种疫苗,但HPV疫苗接种常常延迟,所有年龄组的覆盖率均低于国家目标水平。更好地了解HPV疫苗接种覆盖率在年龄、性别和县域方面的差异,可为全州范围内的针对性干预提供依据。